ReviewFrontiers in bioengineering and biotechnology2025
The mushroom matrix: an engineered mycelium-derived biochar platform for advanced biotechnological applications.
Review in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mushroom cultivation generates vast amounts of spent substrate, while the controlled growth of fungal mycelium offers a dedicated feedstock for advanced materials. This review synthesizes the science of mushroom-derived biochars, a distinct class of biomaterials sourced from this underutilized biomass. This review demonstrates that the inherent biological architecture of fungal matter, specifically its chitinous framework and nitrogen-rich composition, is preserved through pyrolysis to create biochars with superior functionality. We demonstrate how these materials transcend their traditional role as soil amendments to serve as programmable platforms for biotechnology. The review explores how pyrolysis parameters and advanced synthesis methods, such as chemical activation and co-pyrolysis, can be precisely tuned to engineer bespoke properties, including ultra-high surface areas (>1200 m
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.